Page last updated: 2024-11-05

tetraethylammonium and Porphyria, Acute Intermittent

tetraethylammonium has been researched along with Porphyria, Acute Intermittent in 1 studies

Tetraethylammonium: A potassium-selective ion channel blocker. (From J Gen Phys 1994;104(1):173-90)

Porphyria, Acute Intermittent: An autosomal dominant porphyria that is due to a deficiency of HYDROXYMETHYLBILANE SYNTHASE in the LIVER, the third enzyme in the 8-enzyme biosynthetic pathway of HEME. Clinical features are recurrent and life-threatening neurologic disturbances, ABDOMINAL PAIN, and elevated level of AMINOLEVULINIC ACID and PORPHOBILINOGEN in the urine.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
WEHRMACHER, WH1

Other Studies

1 other study available for tetraethylammonium and Porphyria, Acute Intermittent

ArticleYear
New symptomatic treatment for acute intermittent porphyria.
    A.M.A. archives of internal medicine, 1952, Volume: 89, Issue:1

    Topics: Curare; Humans; Porphyria, Acute Intermittent; Tetraethylammonium

1952